Matches in Wikidata for { <http://www.wikidata.org/entity/Q91006368> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91006368 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91006368 description "scientific article published on 01 December 2019" @default.
- Q91006368 description "wetenschappelijk artikel" @default.
- Q91006368 description "наукова стаття, опублікована 1 грудня 2019" @default.
- Q91006368 name "Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study" @default.
- Q91006368 name "Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study" @default.
- Q91006368 type Item @default.
- Q91006368 label "Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study" @default.
- Q91006368 label "Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study" @default.
- Q91006368 prefLabel "Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study" @default.
- Q91006368 prefLabel "Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study" @default.
- Q91006368 P1433 Q91006368-5757AE40-49F2-4CB5-B8E3-56BD688946D6 @default.
- Q91006368 P1476 Q91006368-22DE1B1A-EFE9-4C19-A918-F02FDFA5A62E @default.
- Q91006368 P2093 Q91006368-02BCE321-E17F-4352-95E4-46923617BB80 @default.
- Q91006368 P2093 Q91006368-0EE591D9-067A-4FBD-BB07-A2B949165E42 @default.
- Q91006368 P2093 Q91006368-2AAC8B0D-B0F6-4342-9589-2BDE28A60DF9 @default.
- Q91006368 P2093 Q91006368-D2F6894E-D3DF-4DAA-A627-8EAFD890DF64 @default.
- Q91006368 P2093 Q91006368-E977679A-3D21-4097-A6FA-C3ABAAAFCB82 @default.
- Q91006368 P275 Q91006368-bc255163-a558-4012-b8c9-c0308930e91d @default.
- Q91006368 P304 Q91006368-D5A569B0-0D63-479C-B31B-284B76B39CEA @default.
- Q91006368 P31 Q91006368-577B8774-37DC-4A16-A0A2-DBEA8DA0EDD6 @default.
- Q91006368 P356 Q91006368-CA4FFCCE-CBE0-45FF-A386-67D1282D5164 @default.
- Q91006368 P433 Q91006368-C40F9C09-A91F-4162-8C97-D5A7A5371B20 @default.
- Q91006368 P478 Q91006368-261A0168-EEFE-486C-9589-423D50A51208 @default.
- Q91006368 P577 Q91006368-FDD78C3D-AE1D-4D74-9CB2-AA441F3A8E5A @default.
- Q91006368 P6216 Q91006368-c9a3ba81-f949-4c3c-8843-1d924fc0a04b @default.
- Q91006368 P698 Q91006368-FE54DBE5-1824-4431-86F4-444D0870F782 @default.
- Q91006368 P921 Q91006368-BDE750C4-DBD7-403A-8C60-BAB37E4D0515 @default.
- Q91006368 P932 Q91006368-57ACD16C-9B0F-4EEC-86B6-0B16EEF556EF @default.
- Q91006368 P356 HYZ125 @default.
- Q91006368 P698 31665343 @default.
- Q91006368 P1433 Q2231629 @default.
- Q91006368 P1476 "Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study" @default.
- Q91006368 P2093 "Ayaka Shimizu" @default.
- Q91006368 P2093 "Masako Ura" @default.
- Q91006368 P2093 "Nagane Motoo" @default.
- Q91006368 P2093 "Ryo Nishikawa" @default.
- Q91006368 P2093 "Yasuko Hayashi" @default.
- Q91006368 P275 Q34179348 @default.
- Q91006368 P304 "1016-1023" @default.
- Q91006368 P31 Q13442814 @default.
- Q91006368 P356 "10.1093/JJCO/HYZ125" @default.
- Q91006368 P433 "11" @default.
- Q91006368 P478 "49" @default.
- Q91006368 P577 "2019-12-01T00:00:00Z" @default.
- Q91006368 P6216 Q50423863 @default.
- Q91006368 P698 "31665343" @default.
- Q91006368 P921 Q413299 @default.
- Q91006368 P932 "6923818" @default.